MARKED INHIBITION OF SEBACEOUS GLAND SECRETION FROM COMBINED GLUCOCORTICOID-ESTROGEN TREATMENT

被引：0
|
作者：
POCHI, PE [1 ]
STRAUSS, JS [1 ]
机构：
[1] BOSTON UNIV,SCH MED,DEPT DERMATOL,BOSTON,MA
来源：
CLINICAL RESEARCH | 1975年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A454 / A454
页数：1
相关论文
共 49 条
  • [31] INVIVO EVALUATION OF DOPAMINE RECEPTOR-MEDIATED INHIBITION OF GONADOTROPIN-SECRETION FROM THE PITUITARY-GLAND OF THE GOLDFISH, CARASSIUS-AURATUS
    OMELJANIUK, RJ
    SHIH, SH
    PETER, RE
    JOURNAL OF ENDOCRINOLOGY, 1987, 114 (03) : 449 - 458
  • [32] Influence of Toad Parotid Gland Secretion from Indian Toad (Bufo melanostictus) in Diabetic Rats: An Experimental Evidence of P-Glycoprotein Inhibition
    Madugula, Naveen Kumar
    Neerati, Prasad
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (20) : 125 - 135
  • [33] ESCAPE FROM CHRONIC ESTROGENIC SUPPRESSION OF OVARIAN-FUNCTION IN THE ADULT RHESUS-MONKEY - EVIDENCE FOR CHANGING SENSITIVITY OF GONADOTROPIN-SECRETION TO ESTROGEN INHIBITION
    BILLIAR, RB
    RICHARDSON, DW
    LITTLE, B
    ENDOCRINOLOGY, 1989, 124 (05) : 2373 - 2382
  • [34] Estrogen receptors are expressed in rat cholangiocytes and upregulated after bile duct ligation: Their inhibition with chronic tamoxifen treatment markedly decreases secretin-induced ductal bile secretion.
    Alvaro, D
    Alpini, G
    Glaser, S
    Papa, E
    Onori, P
    Franchitto, A
    Gigliozzi, A
    Caligiuri, A
    LeSage, G
    Gaudio, E
    GASTROENTEROLOGY, 1998, 114 (04) : A1202 - A1203
  • [35] In vivo insulin treatment protects rat islets from cytokine-induced inhibition of insulin secretion despite increased nitric oxide production
    Dunger, A
    Schroder, D
    Kloting, I
    Fischer, U
    DIABETOLOGIA, 1996, 39 : 26 - 26
  • [36] INHIBITION OF CATECHOLAMINE AND 5-HYDROXYTRYPTAMINE INDUCED ENZYME-SECRETION FROM GUINEA-PIG SUBMANDIBULAR-GLAND BY 2-BROMO-D LYSERGIC ACID DIETHYLAMIDE
    CARLSOO, B
    DANIELSSON, A
    MARKLUND, S
    STIGBRAND, T
    EXPERIENTIA, 1975, 31 (04): : 395 - 397
  • [37] RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model
    Jude Canon
    Rebecca Bryant
    Martine Roudier
    Daniel G. Branstetter
    William C. Dougall
    Breast Cancer Research and Treatment, 2012, 135 : 771 - 780
  • [38] RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model
    Canon, Jude
    Bryant, Rebecca
    Roudier, Martine
    Branstetter, Daniel G.
    Dougall, William C.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (03) : 771 - 780
  • [39] Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition
    Boers, Jorianne
    Venema, Clasina M.
    de Vries, Erik F. J.
    Glaudemans, Andor W. J. M.
    Kwee, Thomas C.
    Schuuring, Ed
    Martens, John W. M.
    Elias, Sjoerd G.
    Hospers, Geke A. P.
    Schroder, Carolina P.
    EUROPEAN JOURNAL OF CANCER, 2020, 126 : 11 - 20
  • [40] Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology
    Gitiaux, Cyril
    Bondet, Vincent
    Bekaddour, Nassima
    Nusbaum, Patrick
    Hubas, Arnaud
    Melki, Isabelle
    Bodemer, Christine
    Quartier, Pierre
    Desguerre, Isabelle
    Crow, Yanick J.
    Herbeuval, Jean-Philippe
    Duffy, Darragh
    Bader Meunier, Brigitte
    Rodero, Mathieu P.
    RHEUMATOLOGY, 2020, 59 (05) : 1171 - 1174
12345